
Fresenius Appoints Biopharma Expert to Kabi Management Board
Dr. Michael Schönhofen, head of Fresenius Kabi’s Biopharma business, will leave the company on June 30, 2024, after over 30 successful years. His successor, Dr. Sang-Jin Pak, will join the Fresenius Kabi Management Board on June 1, 2024, ensuring a…












